CYP3A

From WikiMD's Medical Encyclopedia

Revision as of 22:27, 10 March 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

CYP3A is a subfamily of the cytochrome P450 superfamily of enzymes. These enzymes are involved in the metabolism of a variety of substances, including drugs and endogenous compounds. The CYP3A subfamily is one of the most important in human drug metabolism, responsible for the metabolism of approximately half of all marketed drugs.

Function[edit]

The CYP3A enzymes are primarily located in the liver and intestines, where they play a crucial role in the metabolism of drugs and other xenobiotics. They are also found in other tissues, including the kidney, lung, and brain. The enzymes function by oxidizing their substrates, which can lead to their activation, inactivation, or conversion to more easily excreted forms.

Subtypes[edit]

There are several subtypes of CYP3A enzymes, including CYP3A4, CYP3A5, CYP3A7, and CYP3A43. Of these, CYP3A4 is the most abundant and clinically important. It is responsible for the metabolism of a wide range of drugs, including statins, calcium channel blockers, and immunosuppressants.

Clinical significance[edit]

Due to their role in drug metabolism, variations in CYP3A activity can have significant clinical implications. For example, individuals with high CYP3A activity may metabolize drugs more quickly, potentially reducing their effectiveness. Conversely, those with low CYP3A activity may metabolize drugs more slowly, increasing the risk of adverse effects.

In addition, certain drugs and other substances can inhibit or induce CYP3A activity, potentially leading to drug-drug interactions. For example, grapefruit juice is a well-known inhibitor of CYP3A4, and can increase the blood levels of certain drugs.

Research[edit]

Research into CYP3A is ongoing, with a focus on understanding the factors that influence its activity and developing strategies to predict and manage drug-drug interactions. This includes the study of genetic variations that may affect CYP3A activity, as well as the development of new drugs that are less likely to be metabolized by CYP3A.

CYP3A4, one of the enzymes in the CYP3A subfamily.

See also[edit]

References[edit]

<references />

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.